Solentim has opened an office in Shanghai. Solentim China is a joint venture with its longstanding distribution partner Trio Biotech, and is aimed to enhance support for customers and expand commercial activity across the region.
Dr Mark Truesdale, CEO, Solentim, said: “I’m pleased to announce the opening of Solentim’s office in Shanghai as China has been a strong market for us for a number of years. This is an opportunity to deliver an even better service to our customers while our expanding product portfolio, including our new ICONproduct, is opening up new opportunities that can best be serviced locally through our own subsidiary.”
Kun Peng, General Manager of Solentim China, added: “With over 100 customers already in China, this direct investment will help us support and expand our activities, bringing in new technologies for cell therapy and cell line development. Solentim’s technologies for high value cells have made a big impact in the Chinese market over the last few years and with the opening of Solentim China, we look forward to further supporting our customers.”
